Chengdong Liu

机构：Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Southern Medical University · ORCID：0000-0002-3419-4873

发表论文 22 篇 · 总被引 595 次 · h-index 10

代表论文

• miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1 (2018 · Oncogene · 被引 143)
• miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA (2018 · Biochemical and Biophysical Research Communications · 被引 119)
• A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint (2021 · Frontiers in Immunology · 被引 92)
• HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer (2021 · Frontiers in Oncology · 被引 52)
• Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene (2020 · Oncogene · 被引 44)
• EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway (2019 · Bioscience Reports · 被引 35)